Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis
Kosteneffektivität einer Referenz-Ultraschalluntersuchung bei Patient:innen mit tiefer Venenthrombose
Thrombosis and Haemostasis · 01.06.2024 · 124 (06) · 557-567
DOI: 10.1055/a-2213-9230 ↗Auf einen Blick
Eine Modellanalyse fand höhere 1-Jahres-Kosten für Strategien mit Referenz-CUS als ohne. Ein Mortalitätsvorteil zeigte sich nicht.
Fragestellung
Ist eine routinemäßige Referenz-CUS bei Patient:innen mit tiefer Venenthrombose kosteneffektiv?
Methode
Entscheidungsanalytisches Modell mit Patient:innendaten aus einer prospektiven Managementstudie (n = 96) und Abrechnungsdaten; Vergleich von 12 Diagnoseszenarien.
Ergebnisse
Alle 6 Szenarien mit Referenz-CUS hatten höhere geschätzte 1-Jahres-Kosten (€1.763–€1.913) als die 6 ohne Referenz-CUS (€1.192–€1.474). Die geschätzte Mortalität war vergleichbar (14,8–17,9 vs. 14,0–18,5 pro 10.000).
Schlussfolgerung der Autor:innen
Aus Kosteneffektivitätssicht unterstützen die Ergebnisse die routinemäßige Anwendung der Referenz-CUS nicht.
Kernaussagen
- Mit Referenz-CUS: höhere 1-Jahres-Kosten als ohne
- Keine Mortalitätsverbesserung erkennbar
- Die Autor:innen sehen keine Unterstützung für Routineeinsatz
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.06.2024. Verfasst von Cindy M M de Jong und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Venous Thrombosis, Cost-Benefit Analysis, Ultrasonography, Health Care Costs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
The diagnosis of recurrent ipsilateral deep vein thrombosis (DVT) with compression ultrasonography (CUS) may be hindered by residual intravascular obstruction after previous DVT. A reference CUS, an additional ultrasound performed at anticoagulant discontinuation, may improve the diagnostic work-up of suspected recurrent ipsilateral DVT by providing baseline images for future comparison.
Objectives
To evaluate the cost-effectiveness of routinely performing reference CUS in DVT patients.
Methods
Patient-level data (n = 96) from a prospective management study (Theia study; NCT02262052) and claims data were used in a decision analytic model to compare 12 scenarios for diagnostic management of suspected recurrent ipsilateral DVT. Estimated health care costs and mortality due to misdiagnosis, recurrent venous thromboembolism, and bleeding during the first year of follow-up after presentation with suspected recurrence were compared.
Results
All six scenarios including reference CUS had higher estimated 1-year costs (€1,763–€1,913) than the six without reference CUS (€1,192–€1,474). Costs were higher because reference CUS results often remained unused, as 20% of patients (according to claims data) would return with suspected recurrent DVT. Estimated mortality was comparable in scenarios with (14.8–17.9 per 10,000 patients) and without reference CUS (14.0–18.5 per 10,000). None of the four potentially most desirable scenarios included reference CUS.
Conclusion
One-year health care costs of diagnostic strategies for suspected recurrent ipsilateral DVT including reference CUS are higher compared to strategies without reference CUS, without mortality benefit. These results can inform policy-makers regarding use of health care resources during follow-up after DVT. From a cost-effectiveness perspective, the findings do not support the routine application of reference CUS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Biomedical Data Sciences - Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
- National Health Care Institute, The Netherlands.
- Department of Emergency Medicine, Haga Teaching Hospital, The Hague, The Netherlands.
- Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
- Department of Internal Medicine, Østfold Hospital Trust, Gralum, Norway.
ORCID-Profile: Frederikus A Klok
Zitieren
APA
de Jong, C. M. M., van den Hout, W. B., van Dijk, C. E., Heim, N., van Dam, L. F., Dronkers, C. E. A., Gautam, G., Ghanima, W., Gleditsch, J., von Heijne, A., Hofstee, H. M. A., Hovens, M. M. C., Huisman, M. V., Kolman, S., Mairuhu, A. T. A., van Mens, T. E., Nijkeuter, M., van de Ree, M. A., van Rooden, C. J., …, & Klok, F. A. (2024). Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis. Thrombosis and Haemostasis, 124(06), 557-567. https://doi.org/10.1055/a-2213-9230
Vancouver
de Jong CMM, van den Hout WB, van Dijk CE, Heim N, van Dam LF, Dronkers CEA, et al. Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis. Thrombosis and Haemostasis. 2024;124(06):557-567. doi:10.1055/a-2213-9230
BibTeX
@article{deJong2024,
author = {de Jong, Cindy M M and van den Hout, Wilbert B and van Dijk, Christel E and Heim, Noor and van Dam, Lisette F and Dronkers, Charlotte E A and Gautam, Gargi and Ghanima, Waleed and Gleditsch, Jostein and von Heijne, Anders and Hofstee, Herman M A and Hovens, Marcel M C and Huisman, Menno V and Kolman, Stan and Mairuhu, Albert T A and van Mens, Thijs E and Nijkeuter, Mathilde and van de Ree, Marcel A and van Rooden, Cornelis J and Westerbeek, Robin E and Westerink, Jan and Westerlund, Eli and Kroft, Lucia J M and Klok, Frederikus A},
title = {Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {06},
pages = {557--567},
doi = {10.1055/a-2213-9230}
}
EUVIMED